Clearmind starts Phase IIa trial of CMND-100 for alcohol disorder

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/21/2026

1. SPY
2. AMC
3. TSLA
4. MSFT
5. ACN
6. FFAI
7. TLT
8. WBD
9. META
10. NXE

Go back to Clearmind starts Phase IIa trial of CMND-100 for alcohol disorder
(NASDAQ: CMND) Delayed: 0.80 --0 (-0%)
Previous Close $0.80    52 Week High $ 
Open $0.80    52 Week Low $ 
Day High $0.80    P/E N/A 
Day Low $0.80    EPS $ 
Volume 11,863